Does PALBOCICLIB Cause Neutrophil count increased? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Neutrophil count increased have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
51
Reports of Neutrophil count increased with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
17
Deaths
18
Hospitalizations
How Dangerous Is Neutrophil count increased From PALBOCICLIB?
Of the 51 reports, 17 (33.3%) resulted in death, 18 (35.3%) required hospitalization, and 10 (19.6%) were considered life-threatening.
Is Neutrophil count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Neutrophil count increased?
CLOZAPINE (3,125)
PREDNISONE (365)
RITUXIMAB (346)
CLOZARIL (224)
OLANZAPINE (220)
METHYLPREDNISOLONE (202)
CYCLOPHOSPHAMIDE (177)
ADALIMUMAB (175)
ALEMTUZUMAB (171)
PACLITAXEL (159)
Which PALBOCICLIB Alternatives Have Lower Neutrophil count increased Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID